AB141729
RWJ-60475 (AM)3, CD45 tyrosine phosphatase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 620.4 g/mol, Purity >95%. CD45 tyrosine phosphatase inhibitor (IC50 = 2 μM). Cell permeable. Inhibits ADP induced platelet aggregation and IL-2 production in vitro.
1 Images
- Chemical Structure
Lab
Chemical Structure - RWJ-60475 (AM)3, CD45 tyrosine phosphatase inhibitor (AB141729)
2D chemical structure image of ab141729, RWJ-60475 (AM)3, CD45 tyrosine phosphatase inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Developmental cell 31:420-33 PubMed25458010
2014
DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis.
Applications
Unspecified application
Species
Unspecified reactive species
Stefano Marchesi,Francesca Montani,Gianluca Deflorian,Rocco D'Antuono,Alessandro Cuomo,Serena Bologna,Carmela Mazzoccoli,Tiziana Bonaldi,Pier Paolo Di Fiore,Francesco Nicassio
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com